|
|||||
|
|
Efficacy and safety of extended‐release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial‐onset seizures: a randomized controlled trial |
|
| Authors: | J.A. French S.T. Brittain J.K. Johnson the PROSPER Investigators Study Group |
| Affiliation: | 1. NYU Comprehensive Epilepsy Center, , New York, NY, USA;2. Supernus Pharmaceuticals Inc., , Rockville, MD, USA |
| Abstract: | |
| Keywords: | extended‐release oxcarbazepine partial‐onset seizures adjunctive therapy refractory epilepsy |